A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Subjects With Atopic Dermatitis (AD)

Condition:   Atopic Dermatitis Intervention:   Biological: Nemolizumab Sponsor:   Galderma R&D Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials